Trending News
News
News
MicroDose Technologies Announces Achievement of Phase I Clinical Milestone under Collaboration with Merck
The milestone signals the initiation by Merck of a Phase I clinical study of an investigational compound using the MicroDose DPI technology.
News
Stanford Medicine Explores the Complex World of Clinical Trials
The summer issue of Stanford Medicine magazine explores clinical trials in a special report, “Trials on trial: Clinical studies under the microscope.”
News
Harvard University and Oxford Nanopore Technologies Announce Licence Agreement
The agreement aims to progress nanopore science by integrating Harvard discoveries with technology in development at Oxford Nanopore.
News
Researchers Uncover West Nile’s Targets
Screening the entire human genome, a team headed by Yale University scientists has identified several hundred genes that impact West Nile virus infection.
News
Researchers Discover Remnant of an Ancient ‘RNA World’
Yale researchers describe some bacterial cells can swim, morph into new forms and even become dangerously virulent.
News
Recipe for Cell Reprogramming Adds Protein
A drug-like molecule can be substituted for the cancer gene c-Myc, one of four genes added to adult cells to reprogram them to an embryonic-stem-cell-like state, says Whitehead researchers.
News
Putting microRNAs on the Stem Cell Map
Whitehead researchers have now discovered how microRNAs fit into the map of embryonic stem cell circuitry.
News
PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games
PerkinElmer instrumentation, software and expertise are supporting testing for volatile organic compounds in beverages and pesticides in food products.
News
Vitamin C Injections Slow Tumor Growth in Mice
The researchers traced ascorbate's anti-cancer effect to the formation of hydrogen peroxide in the extracellular fluid surrounding the tumors.
News
Ore Pharmaceuticals Acquires Rights to Develop a Second Drug Candidate from Roche
Ore Pharmaceuticals files for patents, plans to develop and out-license candidate for metabolic conditions such as obesity or high cholesterol.
Advertisement